Résumé
The aim of the study is to compare the expression level of candidate genes between patients suffering from a severe major depressive episode (MDE) and controls, and also among patients during MDE evolution. After a comprehensive review of the biological data related to mood disorders, we initiated a hypothesis-driven exploration of candidate mRNAs. Using RT-qPCR, we analyzed peripheral blood mononuclear cells (PBMCs) mRNA obtained from a homogeneous population of 11 patients who suffered from severe melancholic MDE. To assess the evolution of MDE, we analyzed PBMC mRNAs that were collected on Day 1 and 8 weeks later. Data from these patient samples were analyzed in comparison to age- and sex-matched healthy controls. Among 40 candidate genes consistently transcribed in PBMCs, 10 were differentially expressed in at least one comparison. We found that variations of mRNA levels for
NRG1,
SORT1 and
TPH1 were interesting state-dependent biological markers of the disease. We also observed that variations in other mRNA expression were associated with treatment efficacy or clinical improvement (
CREB1,
HDAC5,
HSPA2,
HTR1B,
HTR2A, and
SLC6A4/5HTT). Significantly,
5HTT exhibited a strong correlation with clinical score evolution. We also found a state-independent marker,
IL10. Moreover, the analysis of 2 separate MDEs concerning a same patient revealed comparable results for the expression of
CREB1,
HSPA2,
HTR1B,
NRG1 and
TPH1. Overall, our results indicate that PBMCs obtained at different time points during MDE progression represent a promising avenue to discover biological markers for depression.